These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31996441)

  • 1. Diagnostic Mycology: Xtreme Challenges.
    Wickes BL; Romanelli AM
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31996441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.
    Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changing Trends in Isolation Frequencies and Species of Clinical Fungal Strains: What Do the 12-years (2008-2019) Mycology Laboratory Data Tell About?].
    Gülmez D; Sığ AK; Akar N; Duyan S; Arıkan Akdağlı S
    Mikrobiyol Bul; 2021 Jan; 55(1):53-66. PubMed ID: 33590981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal susceptibility testing: where are we now?
    Patterson TF
    Transpl Infect Dis; 2002; 4 Suppl 3():38-45. PubMed ID: 12486791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance.
    Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP
    Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing].
    Gadea I; Cuenca-Estrella M; Martín E; Pemán J; Pontón J; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 2007 May; 25(5):336-40. PubMed ID: 17504688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Clark NM; Grim SA; Lynch JP
    Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility testing. New technology and clinical applications.
    Pfaller MA; Yu WL
    Infect Dis Clin North Am; 2001 Dec; 15(4):1227-61. PubMed ID: 11780273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antifungal susceptibility testing.
    Hoffman HL; Pfaller MA
    Pharmacotherapy; 2001 Aug; 21(8 Pt 2):111S-123S. PubMed ID: 11501985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular techniques in mycology].
    Rodríguez-Tudela JL; Cuesta I; Gómez-López A; Alastruey-Izquierdo A; Bernal-Martínez L; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():47-53. PubMed ID: 19100167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa.
    Osaigbovo II; Govender NP; Jordan AM; Bongomin F; Meya DB; Kanyua A; Mashedi OM; Koffi D; Loyse A; Sturny-Leclère A; Gangneux JP; Denning DW; Chiller T; Cornely OA; Oladele RO
    Med Mycol; 2024 Jan; 62(1):. PubMed ID: 38154488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal adjuvants: Preserving and extending the antifungal arsenal.
    Butts A; Palmer GE; Rogers PD
    Virulence; 2017 Feb; 8(2):198-210. PubMed ID: 27459018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility testing: technical advances and potential clinical applications.
    Pfaller MA; Rex JH; Rinaldi MG
    Clin Infect Dis; 1997 May; 24(5):776-84. PubMed ID: 9142769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal Resistance: An Emerging Reality and A Global Challenge.
    Kontoyiannis DP
    J Infect Dis; 2017 Aug; 216(suppl_3):S431-S435. PubMed ID: 28911044
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and validation of a molecular method for the diagnosis of medically important fungal infections.
    De Marco D; Perotti M; Ossi CM; Burioni R; Clementi M; Mancini N
    New Microbiol; 2007 Jul; 30(3):308-12. PubMed ID: 17802916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Diagnostics and Therapeutics for Invasive Fungal Infections.
    Friedman DZP; Schwartz IS
    Infect Dis Clin North Am; 2023 Sep; 37(3):593-616. PubMed ID: 37532392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging fungal resistance.
    Baddley JW; Moser SA
    Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.